OCGN
Ocugen, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Ocugen (OCGN) Stock: Buy, Sell, or Hold?
$0.96
+0.01 (+1.09%)
▲
5d:
+9.82%
30d:
+8.47%
90d:
-28.86%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect OCGN Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (33%)
Quality Score
35/100
Position
EXTENDED
30-Day Fair Range
$0.75 – $0.96
Position: EXTENDED
Forward P/E & Valuation
-5.3x
CHEAP
vs 40.6x historical avg
Wall Street Target
$12.17
+1166.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.69 / $1.06
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: OCGN shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When OCGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: OCGN is currently trading at $0.96, which is considered extended relative to its 30-day fair value range of $0.75 to $0.96. From a valuation perspective, the stock is trading at a discount (Forward PE: -5.3) compared to its historical average (40.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OCGN is in a strong downtrend. Immediate support is located at $0.69, while resistance sits at $1.05.
Market Sentiment: OCGN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.17 (+1166.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OCGN is in a strong downtrend. Immediate support is located at $0.69, while resistance sits at $1.05.
Market Sentiment: OCGN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.17 (+1166.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.75 -
$0.96
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
33.3%
Trading Range & Key Levels
30-Day Trading Range
$0.75 -
$0.96
Current vs Trading Range
EXTENDED
Support Level
$0.69
Resistance Level
$1.06
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding OCGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1166.8% below Wall St target ($12.17)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-5.34
Wall Street Target
$12.17
(+1166.8%)
Revenue Growth (YoY)
11.4%
PE vs Historical
-5.3 vs 40.6
CHEAP
Share OCGN Analysis
Share this live OCGN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (OCGN)
Bullish
5 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
4 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits is filled with bullish messages about $OCGN, with some traders expressing optimism despite the perceived lack of size and resources at Celairis. No new news articles were found.
Key Retail Themes:
Company size and resources
Confidence in treatment approvals
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:10 PM ET
Data refreshes hourly during market hours. Next update: 8:10 PM
Data refreshes hourly during market hours. Next update: 8:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OCGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$592 | 44 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$302 | 55 HOLD |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 35 SELL |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 67 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$75 | 66 BUY |
Advanced OCGN Option Strategies
Professional options setups generated by AI based on today's OCGN price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive OCGN Research Pages
